A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: Preliminary results of cancer and leukemia group B trial 9780

Published

Journal Article (Review)

Full Text

Duke Authors

Cited Authors

  • Savarese, D; Taplin, ME; Halabi, S; Hars, V; Kreis, W; Vogelzang, N

Published Date

  • October 1, 1999

Published In

Volume / Issue

  • 26 / 5

Start / End Page

  • 39 - 44

Published By

Pages

  • 6

International Standard Serial Number (ISSN)

  • 0093-7754

Language

  • English